Vexizone T 250mg/31.25mg Injection
Marketer
Vexilla Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Vexizone T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg injection combats bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, this dual-action medication requires adherence to the prescribed dosage schedule. Complete the full treatment course, even with symptom improvement, to prevent relapse. Premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate consultation. Seek immediate medical attention for allergic reactions (rash, itching, swelling, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or dizziness. Ensure adequate rest, nutrition, and hydration for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Uses of Vexizone T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Vexizone T 250mg/31.25mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vexizone T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Vexizone T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Vexizone T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Vexizone T 250mg/31.25mg Injection, offer targeted antibacterial action. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Vexizone T 250mg/31.25mg Injection can be administered without adverse consequences when alcohol is also consumed.
PregnancySAFE IF PRESCRIBED
The injectable medication Vexizone T, 250mg/31.25mg, is typically deemed safe for use during gestation. Preclinical trials using animal models have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Vexizone T 250mg/31.25mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Vexizone T 250mg/31.25mg Injection could reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Vexizone T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The 250mg/31.25mg Vexizone T Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage changes for this injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Vexizone T 250mg/31.25mg Injection :
Omit a Vexizone T 250mg/31.25mg Injection dose? Seek medical advice.
Facts to Know About Vexizone T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently